spot_img
Saturday, December 2, 2023

Ysios Capital adds head of Legal from Cuatrecasas

Ysios Capital, a European venture capital manager in the life sciences sector, announced the appointment of Wen Wen Cheng, who joins from Cuatrecasas, as head of Legal

-

Wen Wen joins the Ysios team to take charge of all Legal aspects related to the fund manager and portfolio companies. She will bring his extensive knowledge and experience to all stages of the investment process, from the negotiation of letters of intent and investment and shareholder agreements to all legal documentation accompanying divestments. In her role as head of Legal, she will also be responsible for the Legal advice of the funds managed by Ysios Capital, relations with regulators, and the prevention of money laundering.

Wen Wen is a Law and Business Administration graduate from Universidad Pompeu Fabra. She joined Cuatrecasas in 2012, where she practised as a lawyer specialising in Corporate Law, Mergers and Acquisitions and Real Estate transactions until joining Ysios.

“We are delighted to incorporate a legal profile such as Wen Wen’s, who will undoubtedly bring us great added value in the process of negotiating investment and divestment contracts, as well as in other legal matters of the fund manager. We believe that now is the right time to strengthen this area within the fund manager and take another step forward in our growth plan,” said Julia Salaverria, managing partner of Ysios Capital.

“Ysios Capital is an internationally renowned firm in the European biotech sector with an experienced, diverse, and innovation-driven team. I look forward to contributing to the growth of the company and this promising industry,” said Wen Wen Cheng, new head of Legal at Ysios Capital.

- Advertisement -spot_img
- Advertisement -spot_img

MOST READ NEWS

Multi-law firm advice on Brown‑Forman´s acquisition of Gin Mare

Brown‑Forman Corporation has announced its agreement to purchase the Gin Mare brands from Vantguard and MG Destilerías. Upon completion of the transaction, Brown‑Forman will...

CC advises QuironSalud on sale of hospital in Peru

The divested portfolio consists of QuironSalud's stake in the flagship hospital Clínica Ricardo Palma located in Lima. Entities of the Verme family, who currently...

Evergreen advises Tresmares Capital on its entry into Proteos Biotech

Proteos Biotech specialises in producing recombinant enzymes whose products have high-quality standards backed by various certifications and scientific support. The company develops exclusive assets...
spot_img
spot_img
spot_img
spot_img
- Advertisement -spot_img
error: